Blog - Page 587 of 5641 - QualityStocks

TuesdaySep 26, 2023 11:15 am

Dawson James Small Cap Growth Conference: Exploring a Changing World of Investment Opportunities

Capital marketers, insurance and wealth management experts, investment bankers, individual investors, and research analysts, are invited to attend the Dawson James Small Cap Growth Conference to be held in Wyndham Grand Harborside Jupiter, Jupiter, FL, October 12, 2023. The distinguished conference serves as a hallmark in the financial world, featuring important management experts slated to share cutting-edge innovations, strategies, and growth opportunities. The highly anticipated 8th Annual Investor Conference provides a unique platform for evolving and established small-cap growth companies within the healthcare, technology, and consumer sectors. It’s a unique opportunity for ground-breaking businesses to showcase their products and services…

TuesdaySep 26, 2023 10:35 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Commercial Class 3 EV EPA Certification

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has reached a key milestone. The company announced that it has received full approval from the Environmental Protection Agency (“EPA”) with certification for class 3 EV commercial vehicles; the company received the notification on Sept. 22, 2023. According to the announcement, the company has also completed all testing requirements for its class 3 EV Cab Chassis Truck to meet Federal Motor Vehicle Safety Standards (“FMVSS”) and compliance. Mullen began production on its class 3 EVs last month, with the first vehicles rolling off the assembly line on Aug. 21, 2023.…

TuesdaySep 26, 2023 9:45 am

Amid REE Market Supply Interruptions, Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Presses Forward With Commercial Processing Plant Plans

Ucore Rare Metals Inc. is moving forward with a rare earth element (“REE”) processing facility in Louisiana that will help to establish an American base for the REE supply chain The REE supply chain is currently almost exclusively controlled by the People’s Republic of China thanks to China’s responsibility for 36.7 percent of the world’s REE reserves, 63 percent of REE mining capacity and more than 90 percent of REE refining capacity REE price increases this month as a result of temporary production shutdowns in Myanmar and China underscore the market’s sensitivity to supply interruptions resulting from governmental policies Ucore’s…

TuesdaySep 26, 2023 9:00 am

RVL Pharmaceuticals plc (NASDAQ: RVLP) Looking to Capitalize on UPNEEQ’s Significant Potential

UPNEEQ(R) is the first FDA-approved non-surgical treatment option for acquired blepharoptosis (ptosis), or low-lying eyelid Clinical studies have shown an average one-millimeter lift of the upper eyelid, with results in as little as five minutes post-dose UPNEEQ(R) is available through RVL Pharmaceuticals’ dedicated e-commerce platform, Elevate, which supports subscription ordering by HCPs and RVL Pharmacy patients RVL is poised to be an integral player in the global medical aesthetic market, which is estimated to reach $18 billion by 2027 RVL Pharmaceuticals (NASDAQ: RVLP), is a specialty pharmaceutical company focusing on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, for…

MondaySep 25, 2023 12:47 pm

QualityStocksNewsBreaks – Astra Energy Inc. (ASRE) Announces Strategic Agreement with Holcomb Energy Systems, Board Appointment of Dr. Robert Holcomb

Astra Energy (OTCQB: ASRE) today announced an agreement with Holcomb Energy Systems LLC (“HES”), which secures exclusive worldwide manufacturing rights to the HES In-Line Power Generator (“ILPG”) and the HES Self-Sustaining Power Plant, two exceptional technologies that are poised to revolutionize the energy sector. According to the announcement, the agreement secures the right for Astra to manufacture both products in-house, as well as to sub-license manufacturing rights to qualified joint venture partners. Both HES technologies, which use no fuel, have no moving parts and produce zero emissions, are scalable and hold an exceptionally wide range of applications within the global…

MondaySep 25, 2023 12:26 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Receives EPA Certification for Class 3 EV Commercial Vehicles

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced its achievement of a key milestone with full approval from the Environmental Protection Agency (“EPA”) with certification for Class 3 EV Commercial Vehicles received on Sept. 22, 2023. According to the announcement, Class 3 vehicle production began in August 2023 with the first vehicles rolling off the assembly line on Aug. 21, 2023. In addition, the Mullen Class 3 EV Cab Chassis Truck has completed all required testing requirements for Federal Motor Vehicle Safety Standards (“FMVSS”) and compliance. “I am extremely proud of this important milestone and, now…

MondaySep 25, 2023 11:15 am

Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) Commences Diamond Drilling with Third Drill Hole at PCH Project in Brazil

The global rare earth elements market is expected to grow from 167.99 million tons in 2023, and to 206.25 million tons by 2028 – growing at a CAGR of 4.19% Since starting the project, Appia has commenced diamond drilling in addition to its current reverse circulation and auger drilling campaigns Specimens from the drilling efforts will be submitted to SGS Geosol laboratory, with assays expected two months from submission The global rare earth elements (“REE”) market is expected to grow from 167.99 million tons in 2023 to 206.25 million tons by 2028 – growing at a CAGR of 4.19%. The…

MondaySep 25, 2023 10:53 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Releases Significant Long-Term Survival Improvement Data from ALS Trial

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc. are reporting on long-term follow-up data for participants in the HEALEY ALS Platform Trial; patients in the study were treated with CNM-Au8(R) 30mg for up to 133 weeks. According to the announcement, data from 59 patients shows prolonged life with 49% decreased risk of death for participants compared to PRO-ACT matched placebo over long-term follow-up; data also showed prolonged life with 59% decreased risk of death for participants in an integrated meta-analysis across HEALEY ALS Platform Trial and RESCUE-ALS Trial with CNM-Au8 30mg compared to PRO-ACT matched placebo over long-term follow-up.…

MondaySep 25, 2023 10:30 am

Trial Enrollment Growth Supports Plans of CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Complete Enrollment for Important Brain Cancer Drug Study

CNS Pharmaceuticals is conducting a global clinical trial to evaluate its flagship drug candidate for treating glioblastoma, a deadly brain cancer CNS has enrolled 200 of its planned 243 patients for its clinical trial roster, and anticipates filling out the remainder of patients by year’s end The company is also preparing the interim study analysis for release by year’s end, now that more than 50 percent of the planned patient roster has reached a point necessary for effective comparison of performance of the flagship drug, Berubicin, to that of a standard of care chemotherapy agent The company has stated that…

Site Search

Company Search